If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...

While the exact cause of asthma is unknown, certain genetic factors can increase the risk of developing the disease.

Although cost-related asthma treatment nonadherence has declined in the US, nearly 1 in 6 patients are still nonadherent due to cost concerns.

WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- A set of chameleon-like immune cells could be contributing to severe asthma in ...

Nov. 27, 2024 — A recent trial finds an injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further ...

Members of the team plan to study hundreds or thousands of patients to understand who has the highest cAMP levels and how ...

Researchers at McMaster University have made an important discovery in the field of asthma research, identifying a new ...

The FDA has advised health care professionals and patients with multiple sclerosis that treatment with glatiramer acetate is ...

Impacting millions of children in the U.S. alone, asthma can be particularly problematic to diagnose with specificity — ...

A simple, noninvasive nasal swab identified a predominance of T2-low asthma subtypes in racial and ethnic minority pediatric ...

A recent study has identified a new non-invasive nasal swab test that could change asthma treatment for children, which can ...